跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
MAXGALIN CAPSULE 150MG
Approved
THERAPEUTIC
MAXGALIN CAPSULE 150MG
SUN PHARMACEUTICAL INDUSTRIES LIMITED
🇸🇬 Health Sciences Authority
Approval Date
Aug 16, 2018
Approval ID
a5e834c585d6a625
Company
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Type
Therapeutic
Approval Details
Approval Id
a5e834c585d6a625
Drug Name
MAXGALIN CAPSULE 150MG
Product Name
MAXGALIN CAPSULE 150MG
Approval Number
SIN15524P
Approval Date
2018-08-16
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
N03AX16
Atc Item Name
xn 03 ax 16
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Active Ingredients
PREGABALIN
150.000 mg/cap
PREGABALIN
150.000 mg/cap
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 16, 2018
Approval ID
a5e834c585d6a625
Type
Therapeutic
Back to HSA Approvals
MAXGALIN CAPSULE 150MG - HSA Drug Approval Details